Abstract:Liver cancer is one of the leading causes of death motivating scientists worldwide to synthesize novel therapeutics. Ru(II)-polypyridyl complexes are extensively studied for possible therapeutic and cellular applications due to their tunable coordination chemistry, structural diversity, ligand-exchange kinetics, accessible redox states, and rich photophysical or photochemical properties. Herein, we have synthesized a series of Ru(II) polypyridyl complexes [RuII(N^N) 2 (ox)] ( 1 - 3 ), where ox is oxalate (C2O42-), N^N is 1,10-phenanthroline (phen) ( 1 ), dipyrido[3,2-d:2',3'-f]quinoxaline (dpq) ( 2 ), and dipyrido[3,2,-a:2',3'-c]phenazine (dppz) ( 3 ). The oxalate (ox 2- ) was opted as a bioactive dioxo ligand to prevent hydrolysis in aqueous media, thereby increasing the stability of the Ru(II)-polypyridyl complexes in physiological media. We thoroughly characterized all the complexes using ESI-MS, FT-IR, UV-vis, and 1H NMR spectroscopy and other physicochemical methods. The complexes were stable under physiological conditions and under low-energy green LED light (λirr= 530 nm). However, the photoirradiation of complexes resulted in the efficient generation of singlet oxygen ( 1 O 2 ) as a major reactive oxygen species (ROS). The role of extended aromatic conjugation of the N^N-donor ligands in the complexes was demonstrated on their binding propensities with CT-DNA and bovine serum albumin (BSA). Both DNA intercalation and groove binding are evidenced, while tryptophan (Trp) and tyrosine (Tyr) binding preferences are revealed from the synchronous fluorescence spectral (SFS) of BSA. The cytotoxic profiling of the complexes performed on hepatocellular carcinoma cells (HepG2) in the dark and in the presence of green light indicated their dose-dependent cytotoxicity. The [Ru II (N^N)2(ox)] complexes exhibit enhanced photocytotoxicity mediated by efficient generation of cytotoxic 1 O 2 and DNA interaction. All the complexes internalize to the HepG2 liver cancer cells efficiently and localize to the cytoplasm and nucleus. The complexes exhibited potent anti-proliferative, anti-clonogenic, and anti-migratory effects on the cancer cells, suggesting their potential promise for therapeutic applications.

Novel Ru(II) complexes with multiple anticancer photoreactivity: ligand exchange, photoredox catalysis, reactive oxygen generation and endoperoxide formation

Photoinduced synergistic cytotoxicity towards cancer cells <i>via</i> Ru(II) complexes

Novel Tris-bipyridine Based Ru(II) Complexes as Type-I/-II Photosensitizers for Antitumor Photodynamic Therapy Through Ferroptosis and Immunogenic Cell Death

Dinuclear Tridentate Ru(II) Complex with Strong Near-Infrared Light-Triggered Anticancer Activity

Photocytotoxic Kinetically Stable Ruthenium(II)-N,N-donor Polypyridyl Complexes of Oxalate for Anticancer Activity Against HepG2 Liver Cancer Cells

Increasing the cytotoxicity of Ru(II) polypyridyl complexes by tuning the electron donating ability of 1,10-phenanthroline ligands

Type I Photoreaction and Photoinduced Ferroptosis by a Ru(II) Complex to Overcome Tumor Hypoxia in Photodynamic Therapy

Sonoinduced Tumor Therapy and Metastasis Inhibition by a Ruthenium Complex with Dual Action: Superoxide Anion Sensitization and Ligand Fracture

Biotin-conjugated Ru(II) complexes with AIE characteristics as mitochondria-targeted photosensitizers for enhancing photodynamic therapy by disrupting cellular redox balance

Heteronuclear Ru(II)-Re(I) complexes as potential photodynamic anticancer agents with anti-metastatic and anti-angiogenic activities

A Ru(II) complex-based COX-2 targeting type I photosensitizer evokes ferroptosis and apoptosis

Green Light-Triggered Photocatalytic Anticancer Activity of Terpyridine-Based Ru(II) Photocatalysts

A RuII Polypyridyl Alkyne Complex Based Metal-Organic Frameworks for Combined Photodynamic/Photothermal/Chemotherapy.

Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives

Homo and heterometallic ruthenium and platinum complexes with multiple targets for therapeutic applications: a review

Converting an Almost Noncytotoxic Ru(II) Complex with Photolabile Ligands into a Highly Efficient PACT Agent

Substituent‐Modulated Excited Triplet States and Activities of Ruthenium Complexes for Dual Photodynamic/Sonodynamic Therapy to Cisplatin‐Resistant Non‐Small Cell Lung Cancer

Theranostic TEMPO-functionalized Ru(ii) Complexes As Photosensitizers and Oxidative Stress Indicators

Bithiophene‐Functionalized Infrared Two‐Photon Absorption Metal Complexes as Single‐Molecule Platforms for Synergistic Photodynamic, Photothermal, and Chemotherapy

Oxygen-dependent interactions between the ruthenium cage and the photoreleased inhibitor in NAMPT-targeted photoactivated chemotherapy

Phenanthrene Appending Ruthenium Complexes: DNA Binding, Molecular Docking, TDDFT Calculation, and Photocytoxicity In Vitro